GLYCO-ENGINEERED IMMUNIZATION ANTIGENS

Disclosed are immunization antigens that have been glyco-engineered to include non-native glycosylation patterns with a view to enhance their properties as antigens for use in such areas as vaccination and antibody production. Also disclosed are to means and methods for producing the glycomodified a...

Full description

Saved in:
Bibliographic Details
Main Authors DE JONGH, WILLEM ADRIAAN, SOGAARD, TEIT MAX MOSCOTE, CLEMMENSEN, STINE BROCH
Format Patent
LanguageEnglish
French
Published 16.07.2020
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Disclosed are immunization antigens that have been glyco-engineered to include non-native glycosylation patterns with a view to enhance their properties as antigens for use in such areas as vaccination and antibody production. Also disclosed are to means and methods for producing the glycomodified antigens as well of methods and uses of the glycomodified antigens. L'invention concerne des antigènes d'immunisation qui ont été glycomodifiés pour inclure des motifs de glycosylation non natifs en vue d'améliorer leurs propriétés en tant qu'antigènes destinés à être utilisés dans des domaines comme la vaccination et la production d'anticorps. L'invention concerne également des moyens et des procédés de production des antigènes glycomodifiés ainsi que des procédés et des utilisations des antigènes glycomodifiés.
Bibliography:Application Number: CA20203125806